Phacoemulsification

Subscribe to Selected New Research on Phacoemulsification

2207 relevant articles (157 outcomes, 227 trials/studies) found for this Therapy

Description: A procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. The small incision allows the surgeon to use very few or even no stitches to close the tiny wound. There is usually no need for hospitalization and patients may resume most activities within days. (Cline, et al., Dictionary of Visual Science, 4th ed & In Focus 1993;1(1):1)

Also Known As:

Phacoemulsifications

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 5

Ophthalmologic Surgical Procedures: 6

Refractive Surgical Procedures: 663

Cataract Extraction: 2371

Phacoemulsification: 2207

Experts

1.	Lam, Dennis S C: 11 articles (01/2007 - 11/2002)
2.	Liu, Y: 6 articles (09/2001 - 03/2000)
3.	Lam, D S: 5 articles (12/2001 - 03/2000)
4.	Vajpayee, R B: 4 articles (08/2008 - 05/2001)
5.	Dada, Tanuj: 4 articles (09/2007 - 02/2003)
6.	Lundberg, Björn: 4 articles (08/2007 - 09/2002)
7.	Behndig, Anders: 4 articles (08/2007 - 09/2002)
8.	O'Donoghue, Mark W: 4 articles (12/2006 - 06/2003)
9.	Shingleton, Bradford J: 4 articles (12/2006 - 06/2003)
10.	Liu, David T L: 4 articles (02/2006 - 06/2005)

Related Diseases

1.	Cataract (Cataracts) 09/01/2002 - "CONCLUSION: It is safe and effective for highly myopic patients with cataract to implant a low or negative power Acrysof IOL after phacoemulsification." 01/01/2009 - "CONCLUSIONS: Modified NPDS without scleral implant with early Nd:YAG laser goniopuncture and phacoemulsification for treatment of patients with POAG and cataract is a safe and effective procedure with complete success at 6 months." 07/01/2008 - "CONCLUSION: The phacoemulsification with foldable posterior chamber intraocular lens implantation is beneficial for PACG with cataract, and the curative efficacy of APACG is better than that of CPACG." 04/01/2008 - "CONCLUSIONS: Cataract surgery performed by phacoemulsification has been proven to be effective in improving quality of life, especially in physical aspects, according to the improvement in role limitation due to physical problems. " 07/01/2007 - "PURPOSE: Phacoemulsification cataract surgery is the gold standard for lens removal and continuous curvilinear capsulorhexis is one of the important first steps during the procedure. " Order ALL the reference details at left...
2.	Glaucoma 04/01/2005 - "CONCLUSION: Phacoemulsification in eyes after filtering glaucoma surgery resulted in a stable IOP, a non-significant increase in the number of antiglaucoma medications and a significantly improved BCVA." 06/01/2003 - "CONCLUSION: Clear corneal or scleral tunnel phacoemulsification in the setting of a preexisting glaucoma filter was associated with improved BCVA, a small but statistically significant increase in IOP, and stability in the number of glaucoma medicines required for IOP control over a minimum follow-up of 1 year." 12/01/1999 - "CONCLUSION: Combined phacoemulsification and trabeculectomy is an effective and safe approach for obtaining good visual rehabilitation and glaucoma control." 06/01/2005 - "Our personal experience with 35 patients, operated on for phacoemulsification and deep sclerectomy with external trabeculectomy in the same operation confirms that this combined surgery in a single operation is effective in controlling ocular pressure in glaucoma subjects (mean reduction in tension, 23%), with few complications." 07/01/2000 - "CONCLUSION: In exfoliative eyes, trabecular aspiration in combination with phacoemulsification and IOL implantation is less effective in reducing postoperative IOP and number of glaucoma medications than the standard filtering glaucoma triple procedure. " Order ALL the reference details at left...
3.	Inflammation 03/01/2008 - "RESULTS: Both treatments were equally effective in controlling postoperative inflammation following phacoemulsification. " 05/01/2004 - "CONCLUSION: With appropriate preoperative and postoperative suppression of inflammation, phacoemulsification and intraocular lens implantation are safe procedures leading to visual improvement in patients with Behçet's disease without preexisting fundus lesions." 06/01/1997 - "CONCLUSION: Digen seemed to maintain the properties and activities of each individual drug, making it a promising treatment for reducing inflammation after phacoemulsification." 04/01/1998 - "CONCLUSION: This study shows that the inflammation in the four groups was very low after phacoemulsification by a corneal incision and attempts to explain the impact of the incision length on the breakdown of blood-aqueous barrier." 05/01/2009 - "Effect of room temperature and cooled intraocular irrigating solution on the cornea and anterior segment inflammation after phacoemulsification: a randomized clinical trial." Order ALL the reference details at left...
4.	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 04/01/2003 - "CONCLUSIONS: This pilot study indicates that phacoemulsification and posterior chamber intraocular lens implantation may be useful in the treatment of primary acute angle-closure glaucoma in Chinese patients. " 06/01/2007 - "PURPOSE: To investigate the efficacy of trabeculectomy, phacotrabeculectomy and phacoemulsification in the management of primary angle closure glaucoma (PACG). " 03/01/2006 - "OBJECTIVE: The aim of this study was to compare phacoemulsification in eyes with angle-closure glaucoma to the partner eyes with or without iridectomy or laser iridotomy, respectively. " 09/01/2001 - "[Preliminary clinical study on the management of angle-closure glaucoma by phacoemulsification with foldable posterior chamber intraocular lens implantation]" 08/01/2008 - "PURPOSE: To evaluate effects and safety of primary phacoemulsification plus intraocular lens implantation for controlled chronic angle-closure glaucoma (CACG) or primary angle-closure (PAC). " Order ALL the reference details at left...
5.	Macular Edema 05/01/2007 - "PURPOSE: To evaluate the effectiveness of a nonsteroidal antiinflammatory drug (NSAID) on pseudophakic cystoid macular edema (CME) and determine the efficacy when used preoperatively and after uneventful phacoemulsification surgery. " 06/01/2008 - "CONCLUSIONS: The results in this study suggest that AquaLase liquefaction cataract extraction is as safe as standard US phacoemulsification cataract extraction and may carry less risk for the development of postoperative cystoid macular edema. " 11/01/1979 - "An on-going study of results and complications in a series of 1055 cataract extractions, done by Kelman phacoemulsification with up to five and one-half years' follow-up, showed that the incidence of cystoid macular edema (CME) is significantly less when the posterior capsule is left intact. " 07/01/2008 - "A 67-year-old woman developed refractory pseudophakic cystoid macular edema (CME) after uneventful phacoemulsification. " 05/01/2008 - "Two case reports were on bilateral cystoid macular edema after phacoemulsification in post-LASIK eyes, and unilateral optic disc pit maculopathy after LASIK. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Lidocaine (Xylocaine)
2.	Trypan Blue
3.	bevacizumab
4.	Mitomycin (Mitomycin-C)
5.	Diclofenac (SR 38)
6.	Ophthalmic Solutions (Eye Drops)
7.	Hyaluronic Acid (Hyaluronan)
8.	levobupivacaine (Chirocaine)
9.	Viscoelastic Substances
10.	Ketorolac Tromethamine (Acular)

Related Therapies and Procedures

1.	Intraocular Lens Implantation
2.	Trabeculectomy (Trabeculoplasty)
3.	Intraocular Lenses (Intraocular Lens)
4.	Vitrectomy
5.	Anesthesia

Best Treatments:
Research Summary Report
on Cataract

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 628 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>